APA (7th ed.) Citation

Wessels, A. M. A., Elzinga, F. A., Koppelman, G. H., Akkerman, O. W., Mian, P., & Touw, D. J. (2025). Quantification of Ivacaftor, Tezacaftor, Elexacaftor, and Lumacaftor and their active metabolites in plasma using UHPLC-MS/MS: Doors open to the application of therapeutic drug monitoring in cystic fibrosis treatment. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 1258, 124604. https://doi.org/10.1016/j.jchromb.2025.124604

Chicago Style (17th ed.) Citation

Wessels, A. Mireille A., Femke A. Elzinga, Gerard H. Koppelman, Onno W. Akkerman, Paola Mian, and Daan J. Touw. "Quantification of Ivacaftor, Tezacaftor, Elexacaftor, and Lumacaftor and Their Active Metabolites in Plasma Using UHPLC-MS/MS: Doors Open to the Application of Therapeutic Drug Monitoring in Cystic Fibrosis Treatment." Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences 1258 (2025): 124604. https://doi.org/10.1016/j.jchromb.2025.124604.

MLA (9th ed.) Citation

Wessels, A. Mireille A., et al. "Quantification of Ivacaftor, Tezacaftor, Elexacaftor, and Lumacaftor and Their Active Metabolites in Plasma Using UHPLC-MS/MS: Doors Open to the Application of Therapeutic Drug Monitoring in Cystic Fibrosis Treatment." Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences, vol. 1258, 2025, p. 124604, https://doi.org/10.1016/j.jchromb.2025.124604.